Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Study Evaluating the Addition of Fulvestrant to Erlotinib in Stage IIIB/IV Non-Small Cell Lung Cancer

This study has been terminated.
(Study was terminated due to slow subject accrual)
Information provided by (Responsible Party):
Lyudmila Bazhenova, M.D., University of California, San Diego Identifier:
First received: December 26, 2007
Last updated: July 12, 2012
Last verified: July 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: July 2012
  Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)